For the latest news on Darwin and our investments please see below.
Darwin Private Equity (“Darwin”) has today entered into an agreement to acquire The A & A Group Limited (“Allen & Allen”) and Hyperformance Limited (together the “A&A Group”) in a management buyout. The transaction is subject to change of control approval from the Financial Services Authority. Read more
Darwin Private Equity is pleased to announce that Stephen Delaney has been promoted to Principal with immediate effect. Read more
Darwin Private Equity (“Darwin”) has completed the management buyout of Attenda Ltd (“Attenda”), a leading provider of business critical managed hosting services to UK enterprises, for £50 million. Read more
Euroffice, the online office supplies company backed by Darwin Private Equity, today announces the acquisition of UK Office Direct Limited. Read more
Darwin Private Equity has today completed the sale of Maxinutrition to GlaxoSmithKline plc for £162 million. Read more
Darwin Private Equity is pleased to announce that Paul Burton and David Coombs have been promoted to Investment Director with immediate effect. Read more
Darwin Private Equity (“Darwin”) has today entered into an agreement to sell Maxinutrition Group Holdings Limited (“Maxinutrition”) to GlaxoSmithKline (“GSK”) for £162 million. The transaction is subject to approval from the Office of Fair Trading. Maxinutrition, the parent company of Maximuscle, Maxifuel and Maxitone, is Europe’s leading sports nutrition company. Read more
Darwin Private Equity (“Darwin”) has completed its third investment of 2010, with the acquisition of a majority stake in Euroffice Ltd (“Euroffice”). Read more
Darwin Private Equity ("Darwin") has today acquired Fenn Wright Manson, a leading British womenswear brand in the retail and wholesale market with stores and concessions in the UK and abroad. Read more